A detailed history of Prostatis Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Prostatis Group LLC holds 63,516 shares of ABBV stock, worth $12.7 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
63,516
Previous 1,431 4338.57%
Holding current value
$12.7 Million
Previous $215 Million 8.24%
% of portfolio
0.09%
Previous 0.11%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $8.23 Million - $10.2 Million
62,085 Added 4338.57%
63,516 $197 Million
Q1 2023

May 22, 2023

SELL
$144.61 - $166.54 $1,446 - $1,665
-10 Reduced 0.69%
1,431 $215 Million
Q4 2022

Mar 28, 2023

SELL
$138.31 - $165.87 $9.55 Million - $11.5 Million
-69,063 Reduced 97.96%
1,441 $233 Million
Q4 2022

Mar 23, 2023

BUY
$138.31 - $165.87 $5.9 Million - $7.08 Million
42,661 Added 153.22%
70,504 $233 Million
Q3 2022

Mar 23, 2023

SELL
$134.21 - $153.93 $509,729 - $584,626
-3,798 Reduced 12.0%
27,843 $161 Million
Q2 2022

Mar 23, 2023

SELL
$137.62 - $174.96 $246,339 - $313,178
-1,790 Reduced 5.35%
31,641 $185 Million
Q1 2022

Mar 23, 2023

BUY
$131.98 - $163.75 $705,037 - $874,752
5,342 Added 19.02%
33,431 $196 Million
Q4 2021

Mar 23, 2023

BUY
$107.43 - $135.93 $591,509 - $748,430
5,506 Added 24.38%
28,089 $164 Million
Q3 2021

Mar 23, 2023

SELL
$106.4 - $120.78 $341,224 - $387,341
-3,207 Reduced 12.44%
22,583 $130 Million
Q2 2021

Mar 23, 2023

BUY
$105.21 - $117.21 $330,675 - $368,391
3,143 Added 13.88%
25,790 $138 Million
Q1 2021

Mar 23, 2023

BUY
$102.3 - $112.62 $22,506 - $24,776
220 Added 0.98%
22,647 $130 Million
Q4 2020

Mar 23, 2023

BUY
$80.49 - $108.67 $315,520 - $425,986
3,920 Added 21.18%
22,427 $128 Million
Q3 2020

Mar 23, 2023

SELL
$85.91 - $100.83 $181,356 - $212,852
-2,111 Reduced 10.24%
18,507 $104 Million
Q2 2020

Mar 23, 2023

BUY
$73.37 - $98.18 $330,605 - $442,399
4,506 Added 27.97%
20,618 $116 Million
Q1 2020

Mar 23, 2023

SELL
$64.5 - $97.79 $161,572 - $244,963
-2,505 Reduced 13.46%
16,112 $81.8 Million
Q4 2019

Mar 23, 2023

BUY
$72.13 - $90.25 $1.34 Million - $1.68 Million
18,617 New
18,617 $98.2 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Prostatis Group LLC Portfolio

Follow Prostatis Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.